Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3167
2021 3302
2022 2785
2023 1870
2024 569

Text availability

Article attribute

Article type

Publication date

Search Results

10,199 results

Results by year

Filters applied: . Clear all
Page 1
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021.
Douglas AP, Smibert OC, Bajel A, Halliday CL, Lavee O, McMullan B, Yong MK, van Hal SJ, Chen SC; Australasian Antifungal Guidelines Steering Committee. Douglas AP, et al. Intern Med J. 2021 Nov;51 Suppl 7:143-176. doi: 10.1111/imj.15591. Intern Med J. 2021. PMID: 34937136
Other emerging patient risk groups include patients in the intensive care setting with severe respiratory viral infections, including COVID-19. ...
Other emerging patient risk groups include patients in the intensive care setting with severe respiratory viral infections, including …
Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
Carod-Artal FJ. Carod-Artal FJ. Rev Neurol. 2021 Jun 1;72(11):384-396. doi: 10.33588/rn.7211.2021230. Rev Neurol. 2021. PMID: 34042167 Free article. Review. English, Spanish.
The epidemiological evidence, diagnostic criteria and pathogenesis of post-COVID-19 syndrome are reviewed. DEVELOPMENT: Post-COVID-19 syndrome is defined by persistent clinical signs and symptoms that appear while or after suffering COVID-19 …
The epidemiological evidence, diagnostic criteria and pathogenesis of post-COVID-19 syndrome are reviewed. DEVELOPMENT: Post- …
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. Tajbakhsh A, et al. Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357. doi: 10.1080/14787210.2020.1822737. Epub 2020 Sep 28. Expert Rev Anti Infect Ther. 2021. PMID: 32921216 Review.
In addition to infecting the respiratory system, COVID-19 also has adverse effects on the cardiovascular system. COVID-19 causes acute myocardial injuries, as well as chronic damage to the cardiovascular system. ...Myocardial damage is closely related …
In addition to infecting the respiratory system, COVID-19 also has adverse effects on the cardiovascular system. COVID- …
The Stanford Hall consensus statement for post-COVID-19 rehabilitation.
Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. Barker-Davies RM, et al. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31. Br J Sports Med. 2020. PMID: 32475821 Free PMC article.
Long-term sequelae of COVID-19 are unknown, but evidence from previous CoV outbreaks demonstrates impaired pulmonary and physical function, reduced quality of life and emotional distress. Many COVID-19 survivors who require critical care may dev …
Long-term sequelae of COVID-19 are unknown, but evidence from previous CoV outbreaks demonstrates impaired pulmonary and physi …
ESCMID COVID-19 living guidelines: drug treatment and clinical management.
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Paño-Pardo JR, Power NR, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Zollner-Schwetz I, Rodríguez-Baño J. Bartoletti M, et al. Clin Microbiol Infect. 2022 Feb;28(2):222-238. doi: 10.1016/j.cmi.2021.11.007. Epub 2021 Nov 22. Clin Microbiol Infect. 2022. PMID: 34823008 Free PMC article.
SCOPE: In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID-19-related issues, including treatment of COVID-19. METHODS: An ESCMID COVID-19 guidelines task force …
SCOPE: In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID …
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes IB, Sattar N, Stamm TA, Takeuchi T, Trauner M, van der Heijde D, Voshaar M, Winthrop KL, Ravelli A, Betteridge N, Burmester GR, Bijlsma JW, Bykerk V, Caporali R, Choy EH, Codreanu C, Combe B, Crow MK, de Wit M, Emery P, Fleischmann RM, Gabay C, Hetland ML, Hyrich KL, Iagnocco A, Isaacs JD, Kremer JM, Mariette X, Merkel PA, Mysler EF, Nash P, Nurmohamed MT, Pavelka K, Poor G, Rubbert-Roth A, Schulze-Koops H, Strangfeld A, Tanaka Y, Smolen JS. Aletaha D, et al. Ann Rheum Dis. 2023 Jun;82(6):773-787. doi: 10.1136/ard-2022-222784. Epub 2022 Aug 11. Ann Rheum Dis. 2023. PMID: 35953263 Free article.
BACKGROUND: Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of immune-mediated inflammatory disease. ...RESULTS: The consensus process covered relevant aspects of dosing and populations for different indications of IL-6 pathway inhibit …
BACKGROUND: Targeting interleukin (IL)-6 has become a major therapeutic strategy in the treatment of immune-mediated inflammatory dis …
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations.
Passamonti F, Nicastri E, Di Rocco A, Guarini A, Ibatici A, Luminari S, Mikulska M, Visco C. Passamonti F, et al. Hematol Oncol. 2023 Feb;41(1):3-15. doi: 10.1002/hon.3086. Epub 2022 Oct 25. Hematol Oncol. 2023. PMID: 36251481 Free PMC article. Review.
To this purpose, we will first provide an overview of the main data concerning prognostic factors and fatality rate of lymphoma patients who develop COVID-19; the outcomes of COVID-19 vaccination will also be addressed. We will then discuss current …
To this purpose, we will first provide an overview of the main data concerning prognostic factors and fatality rate of lymphoma patients who …
Management of post-acute covid-19 in primary care.
Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Greenhalgh T, et al. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026. BMJ. 2020. PMID: 32784198 No abstract available.
Pain Management Revisited.
Carr E. Carr E. Clin J Oncol Nurs. 2021 Aug 1;25(4):361-362. doi: 10.1188/21.CJON.361-362. Clin J Oncol Nurs. 2021. PMID: 34269344 Free article.
Much has happened during the past two years that influences the effective management of pain in patients with cancer-not the least of which is a clinical environment that has been changed by the COVID-19 pandemic....
Much has happened during the past two years that influences the effective management of pain in patients with cancer-not the least of which …
Vitamin D in the older population: a consensus statement.
Giustina A, Bouillon R, Dawson-Hughes B, Ebeling PR, Lazaretti-Castro M, Lips P, Marcocci C, Bilezikian JP. Giustina A, et al. Endocrine. 2023 Jan;79(1):31-44. doi: 10.1007/s12020-022-03208-3. Epub 2022 Oct 26. Endocrine. 2023. PMID: 36287374 Free PMC article. Review.
Dissemination of the results of the conference through publications in peer-reviewed journals is an important means by which the most up to date information can be shared with physicians, investigators, and other health care professionals. Vitamin D and aging, the subject …
Dissemination of the results of the conference through publications in peer-reviewed journals is an important means by which the most up to …
10,199 results
You have reached the last available page of results. Please see the User Guide for more information.